The APC1 Concept of Type I Diabetes

References

• Kolb-Bachofen V., Kolb H. A role for macrophages in the pathogenesis of type I diabetes. Autoimmunity 1989; 3: 145–155
   PubMed Web of Science ®Google Scholar
• Leiter E. H., Prochazka M., Coleman D. L. Animal model of human disease. The non-obese diabetic (NOD) mouse. Amer J Pathol 1987; 128: 380–391
   PubMed Web of Science ®Google Scholar
• Scott J. The spontaneously diabetic BB rat: sites of the defects leading to autoimmunity and diabetes mellitus. Curr Top Microbiol Immunol 1990; 156: 1–14
   PubMed Web of Science ®Google Scholar
• Gepts W. Pathologic anatomy of pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619–633
   PubMed Web of Science ®Google Scholar
• Oschilewski U., Kiesel U., Kolb H. Administration of silica prevents diabetes in BB rats. Diabetes 1985; 34: 197–202
   PubMed Web of Science ®Google Scholar
• Charlton B., Bacelj B. A., Mandel T. E. Administration of silica particals or anti-Lyt2 antibodies prevents, β-cell destruction in NOD mice given cyclophosphamide. Diabetes 1988; 37: 930–936
   PubMed Web of Science ®Google Scholar
• Hahnenberg H., Kolb-Bachofen V., Kantwerk-Funke G., Kolb H. Macrophage infiltration precedes and its prerequisite for lymphocytic insulitis in pancreatic islets of prediabetic BB rats. Diabetologia 1989; 32: 126–129
   PubMedGoogle Scholar
• Lee K. U., Amano K., Yoon J. W. Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes 1989; 37: 989–991
   Google Scholar
• Hutchings P., Rosen H., O'Reilly L., Simpson E., Gordon S., Cooke A. Transfer of diabetes in mice is prevented by blockade of adhesion-promoting receptor on macrophages. Nature 1990; 348: 639–642
   PubMed Web of Science ®Google Scholar
• Voorby H. A.M, Jeucken P. H. M., Kabel P. J., De-Haan M., Drexhage H. A. Dendritic cells and scavenger macrophages in the pancreatic islets of prediabetic BB rats. Diabetes 1989; 38: 1623–1629
   PubMedGoogle Scholar
• Jansen A., Homo-Delarche F., Hooijkaas H., Leenen P. J., Dardenne M., Drexhage H. A. Immunohisto-chemical characterization of monocyte-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 1994; 43: 667–675
   PubMed Web of Science ®Google Scholar
• Lo D., Reilly C. R., Scott B., Liblau R., McDevitt H. O., Burkly L. C. Antigen-presenting cells in adoptively tranferred and spontaneous autoimmune diabetes. Eur J Immunol 1993; 23: 1693–1698
   PubMed Web of Science ®Google Scholar
• Ziegler A. G., Erhard J., Lampeter E. F., Nagelkerken L. M., Standi E. Involvement of dendritic cells in early insulitis of BB rats. J Autoimmun 1992; 5: 571–579
   PubMedGoogle Scholar
• Jarpe A. J., Hickman M. R., Anderson J. T., Winter W. E., Peck A. B. Flow cytometric numeration of mononuklear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes. Reg Immunol 1991; 3: 305–317
   Google Scholar
• DˆAndrea A., Rengaraju M., Valiante N. M., Chehimi J., Kubin M., Aste-Amezaga M., Chan S. H., Kobayashi M., Young D., Nickbarg E., Chizzonite R., Wolf S. F., Trinchieri G. Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuklear cells. J Exp Med 1992; 176: 1387–1392
   PubMedGoogle Scholar
• Georgiou H. M., Constantinou D., Mandel T. E. Prevention of autoimmunity in nonobese diabetic (NOD) mice by neonatal transfer of allogenic thymic macrophages. Autoimmunity 1995; 21: 89–97
   PubMed Web of Science ®Google Scholar
• Shimada A., Takei I., Mauyama T., Kasuga A., Kasa-Tani T., Watanabe K., Asaba Y., Ishii T., Tadakuma T., Habu S. Acceleration of diabetes in young NOD mice with peritoneal macrophages. Diabetes Res Clin Pract 1994; 24: 69–76
   PubMedGoogle Scholar
• Boyd R. L., Hugo P. Towards an intergtated view of thymopoiesis. Immunol Today 1991; 12: 71–79
   PubMedGoogle Scholar
• Serreze D. V. Autoimmune diabetes results from genetic defects manifest by antigen presenting cell. FASEB J 1993; 7: 1092–1096
   PubMed Web of Science ®Google Scholar
• Todd J. A., Aitman T. J., Cornall R. J., Gosh S., Hall J. R. S., Hearne C. M., Knight A. M., Love J. M., Mc-Aleer M. A., Prins J. B., Rodrigues N., Lathorp M., Pres-Sey A., DeLarto N. H., Peterson L. B., Wicker L. S. Genetic analysis of autoimmune type I diabetes mellitus in mice. Nature 1991; 351: 542–547
   PubMed Web of Science ®Google Scholar
• Davies J. L., Kawaguchi Y, Bennett S. T., Copemann J. B., Cordell H. J., Pritchard L. E., Reed P. W., Gough S. C. L., Jenkins S. C, Palmer S. M., Balfour K. M., Rowe B. R., Farrall M., Barnett A. H., Bain S. C., Todd J. A. A genome-wide search for human type I diabetes susceptible genes. Nature 1994; 371: 130–136
   PubMed Web of Science ®Google Scholar
• Todd J. A., Bain S. C. A practical approach to identification of susceptible genes for IDDM. Diabetes 1992; 41: 1029–1034
   PubMedGoogle Scholar
• Rothe H., Jenkins N. A., Copeland N. G., Kolb H. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near ldd2. J Clin Invest 1997; 99: 469–474
   PubMed Web of Science ®Google Scholar
• Jenkins N. A., Rothe H., Gilbert D. J., Copeland N. G., Kolb H. Mapping of the gene for inducible NO symthase of mouse macrophages to chromosome 11 close to evi-2, nu and Idd-4. Genomics 1994; 19: 402–405
   PubMed Web of Science ®Google Scholar
• Ballantyne C. M., Kozak C. A., O'Brien W. E., Bea-Udet A. L. Assignment of the gene for intercellular adhesion molecul-1 (ICAM-1) to proximal mouse chromosome 9. Genomics 1991; 9: 547–550
   PubMedGoogle Scholar
• Russel P. J., Steinberg A. D. Sudies of peritoneal macrophage function in mice with systemic lupus erythematosus: depressed phagocytosis of opsonized sheep erythrocytes in vitro. Clin Immunol Immunophathol 1983; 27: 387–402
   PubMedGoogle Scholar
• Luqmani R., Sheeran T., Robinson M., Richardson K., Winkels J., Emery P. Sytemic cytokine measurements: their role in monitoring the response to therapy in patients with rheumatois arthritis. Clin Exp Rheumatol 1994; 12: 503–508
   PubMed Web of Science ®Google Scholar
• Serreze D. V., Gaskin H. R., Leiter E. H. Defects in differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 1993; 150: 2534–2543
   PubMed Web of Science ®Google Scholar
• Jacob C. O., Aiso S., Michie S. A. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similiarities between TNFo? and interleukin 1. Immunology 1990; 87: 968–972
   Google Scholar
• Lapchak P. H., Guilbert L. J., Rabinovitch A. Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Fre-unďs adjuvant: A possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes. Clin Immunol. Immunopathol 1992; 65: 129–134
   PubMedGoogle Scholar
• Barel D., Brennan D. C., Jevnikar A. M. Enhanced tumor necrosis factor in anti-CD3 antibody stimulated diabetic NOD mice: Modulation by PGE1 and dietary lipid. Autoimmunity 1992; 13: 141–149
   PubMed Web of Science ®Google Scholar
• Rothe H., Fehsel 'K., Kolb H. A macrophage defect in diabetes prone BB rats. Diabetologia 1990; 33: 573–575
   PubMedGoogle Scholar
• Rothe H., Ongeren C., Martin S., Kolb H. Abnormal TNFa production in diabetes-prone BB rats: enhanced TNFa expression and defective PGE2 feedback inhibition. Immunology 1994; 81: 407–413
   PubMedGoogle Scholar
• Rothe H., Öngören C, Rösen P., Kolb H. Genetic analysis of aberrant TNF α production in prediabetic BB rats. Transplantation Proceedings 1993; 25: 2833
   PubMedGoogle Scholar
• Mosmann T. R., Cherwinski I. I., Bond M. VV., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 185: 2348–2357
   Google Scholar
• Mosmann T. R., Coffman R. L. Thl and Th2 cells different patterns of lymphokine secretion to different functional properties. Annual Rev Immunol 1989; 7: 145–173
   PubMed Web of Science ®Google Scholar
• Shehadeh N. N., LaRosa L., Lafferty K. J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 1993; 6: 291–300
   PubMed Web of Science ®Google Scholar
• Rothe H., Faust H., Schade U., Kleemann R., Bosse G., Hibino T., Martin S., Kolb H. Acceleration of diabetes development in NOD mice by cyclophosphamide is associated with a shift from IL-4 to IFN-gamma production and with enhanced expression of inducible NO-synthase in pancreatic lesions. Diabetologia 1994; 37: 1154–1158
   PubMed Web of Science ®Google Scholar
• Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 1994; 43: 613–621
   PubMed Web of Science ®Google Scholar
• Katz J. D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 268: 1185–1188
   PubMed Web of Science ®Google Scholar
• Healey D., Ozegbe P., Arden S., Chandler P., Hutch-Ton J., Cooke A. In vivo and in vitro specificity of CD4+ Thl and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin Invest 1995; 95: 2979–2985
   PubMed Web of Science ®Google Scholar
• Hancock W. W., Polanski M., Zhang J., Blogg N., Weiner H. L. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and-10, transforming growth factor, an prostaglandine-E. Am J Pathol 1995; 147: 1193–1199
   PubMed Web of Science ®Google Scholar
• Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Ha-Kura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., Kurimoto M. Cloning of a new cytokine that induces IFN-y production by T cells. Nature 1994; 378: 88–91
   Google Scholar
• Wolf S. F., Temple P. A., Kobayashi M., Young D., Dicig M., Lowe L., et al. Cloning of cDNA for natural killer stimulatory factor, a hetrodimeric cytokine with multiple biological effects on T and natural killer cells. J Immunol 1991; 146: 3074–3081
   PubMed Web of Science ®Google Scholar
• Gubler U., Chua A. O., Schoenhaut D. S., Dwyer C M, MaComas W., Motyka R., et al. Co-expression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci 1991; 88: 4143–4147
   PubMed Web of Science ®Google Scholar
• Hsieh C. S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of Thl CD4+ T cells through IL-12 produced by Listeria-induced macorphages. Science 1993; 260: 547–549
   PubMed Web of Science ®Google Scholar
• Manetti R., Parronchi P., Giudizi M. G., Piccini M. P., Maggi E., Trinchieri G., et al. Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 1993; 177: 1199–1204
   PubMed Web of Science ®Google Scholar
• Alfoso L. C. C, Scharton T. M., Vieira L. Q., Wyso-Cka M., Trinchieri G., Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmanial major. Science 1994; 263: 235–237
   PubMedGoogle Scholar
• Trembleau S., Penna G., Bosi E., Mortara A., Gately M. K., Adorini L. Interleukin-12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995; 181: 817–821
   PubMed Web of Science ®Google Scholar
• Micallef M. J., Ohtsuki T., Kohno K., Tanabe F., Us-Hio S., Namba M., Tanimoto T., Torigoe K., Fujii M., Ikeda M. M., Fukuda S., Kurimoto M. Inter-feron-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996; 26: 1647–1651
   PubMed Web of Science ®Google Scholar
• Rothe H., Burkart V., Faust A., Kolb H. Interleukin-12 gene expression is associated with rapid diabetes development in NOD mice. Diabetologia 1996; 39: 119–122
   PubMedGoogle Scholar
• Powrie F., Menon S., Coffman R. L. Interleukin-4 and interleukin-10 synergize to inhibit cell mediated immunity in vivo. Eur J Immunol 1993; 23: 3043–3049
   PubMed Web of Science ®Google Scholar
• Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Thl cells. 1 Immunol 1991; 146: 3444–3451
   PubMed Web of Science ®Google Scholar
• Dandrea A., Asteamezaga M., Valiante N. M., Ma X. J., Kubin M., Trinchieri G. Interleukin-10 (IL-10) inhibits human lymphocyte interferon-gamma production by suppressing natural killer stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 1993; 178: 1041–1048
   PubMedGoogle Scholar
• Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 1549–1555
   PubMed Web of Science ®Google Scholar
• Moore K., O'Garra A., De Wal Malefyt R., Vieira P., Mosmann T. R. Interleukin-10. Annual Rev Immunol 1993; 11: 165–190
   PubMed Web of Science ®Google Scholar
• Pennline K. J., Roquegaffney E., Monahan M. Recombinant human IL-10 prevents the onset of diabetes in nonobese diabetic mouse. Clin Immunol Immunopathol 1994; 71: 169–175
   PubMedGoogle Scholar
• Rabinovitch A., Sorensen O., Suarez-Pinzon W. L., Power R. F., Rajotte R. V., Bleackey R. C. Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice:interleukin-2 and interferone-γ mRNA expression correlate with graft injection and interleukin-10 with graft survival. Diabetologia 1994
   Google Scholar